PL2126049T3 - Przeciwciała przeciwko ludzkiemu wirusowi cytomegalii (HCMV) - Google Patents

Przeciwciała przeciwko ludzkiemu wirusowi cytomegalii (HCMV)

Info

Publication number: PL2126049T3
Authority: PL; Poland
Prior art keywords: hcmv; human cytomegalovirus; antibodies against; against human; infections
Prior art date: 2006-12-15

Application number

PL07857724T

Other languages

English (en)

Inventor

Ada Funaro

Giorgio Gribaudo

Santo Landolfo

Original Assignee

Ribovax Biotechnologies Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-12-15

Filing date

2007-12-17

Publication date

2011-09-30

2006-12-15 Priority claimed from PCT/EP2006/069780 external-priority patent/WO2007068758A1/en

2007-12-17 Application filed by Ribovax Biotechnologies Sa filed Critical Ribovax Biotechnologies Sa

2011-09-30 Publication of PL2126049T3 publication Critical patent/PL2126049T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
- C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
- C07K16/089—Cytomegalovirus
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Virology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biotechnology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Wood Science & Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Tropical Medicine & Parasitology (AREA)
General Engineering & Computer Science (AREA)
Zoology (AREA)
Communicable Diseases (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Mycology (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

PL07857724T 2006-12-15 2007-12-17 Przeciwciała przeciwko ludzkiemu wirusowi cytomegalii (HCMV) PL2126049T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
PCT/EP2006/069780 WO2007068758A1 (en)	2005-12-16	2006-12-15	Methods for obtaining immortalized antibody secreting cells
EP07110693		2007-06-20
PCT/EP2007/064094 WO2008071806A1 (en)	2006-12-15	2007-12-17	Antibodies against human cytomegalovirus (hcmv)
EP07857724A EP2126049B1 (en)	2006-12-15	2007-12-17	Antibodies against human cytomegalovirus (hcmv)

Publications (1)

Publication Number	Publication Date
PL2126049T3 true PL2126049T3 (pl)	2011-09-30

Family

ID=40935039

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL07857724T PL2126049T3 (pl)	2006-12-15	2007-12-17	Przeciwciała przeciwko ludzkiemu wirusowi cytomegalii (HCMV)

Country Status (18)

Country	Link
US (1)	US8153129B2 (pl)
EP (1)	EP2126049B1 (pl)
JP (1)	JP5351041B2 (pl)
KR (1)	KR20090114364A (pl)
CN (1)	CN101627115B (pl)
AT (1)	ATE503769T1 (pl)
AU (1)	AU2007331463B2 (pl)
BR (1)	BRPI0720464A2 (pl)
CA (1)	CA2672703C (pl)
DE (1)	DE602007013618D1 (pl)
DK (1)	DK2126049T3 (pl)
EA (1)	EA018701B1 (pl)
ES (1)	ES2363992T3 (pl)
IL (1)	IL199366A (pl)
NO (1)	NO20092671L (pl)
PL (1)	PL2126049T3 (pl)
PT (1)	PT2126049E (pl)
WO (1)	WO2008071806A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7947274B2 (en)	2007-01-04	2011-05-24	Humabs, LLC.	Human cytomegalovirus neutralising antibodies and use thereof
GB0700133D0 (en)	2007-01-04	2007-02-14	Humabs Llc	Human cytomegalovirus neutralising antibodies and use thereof
US20110171233A1 (en) *	2007-08-22	2011-07-14	Ribovax Biotechnologies S.A.	Antibodies Against Human Cytomegalovirus (HCMV)
EP2352759B1 (en)	2008-07-16	2017-11-01	Institute for Research in Biomedicine	Human cytomegalovirus neutralizing antibodies and use thereof
US8703486B2 (en) *	2008-09-23	2014-04-22	UNIVERSITé LAVAL	Method for polyclonal immunoglobulin G production by human B cells
JP5833565B2 (ja)	2009-12-23	2015-12-16	４−アンティボディ・アクチェンゲゼルシャフト４−ＡｎｔｉｂｏｄｙＡｇ	ヒトサイトメガロウイルスに対する結合メンバー
AR083214A1 (es) *	2010-09-29	2013-02-06	Genentech Inc	Composiciones de anticuerpo anti complejo i de hcmv y metodos de uso
KR20140138971A (ko)	2012-03-28	2014-12-04	제넨테크, 인크.	항-hcmv 이디오타입 항체 및 이들의 용도
KR101581158B1 (ko)	2014-03-26	2015-12-30	울산대학교 산학협력단	거대세포바이러스 실제 감염 여부를 진단하기 위한 거대세포바이러스의 감염 해석 모델
RU2699715C2 (ru) *	2014-05-19	2019-09-09	Ф. Хоффманн-Ля Рош Аг	Способ получения полипептидов
US10611800B2 (en)	2016-03-11	2020-04-07	Pfizer Inc.	Human cytomegalovirus gB polypeptide
US11629172B2 (en)	2018-12-21	2023-04-18	Pfizer Inc.	Human cytomegalovirus gB polypeptide
CN118465272B (zh) *	2019-12-04	2025-08-19	珠海泰诺麦博制药股份有限公司	抗人巨细胞病毒抗体及其用途
TWI810589B (zh)	2020-06-21	2023-08-01	美商輝瑞股份有限公司	人巨細胞病毒糖蛋白Ｂ（ｇＢ）多肽
CN115947869B (zh) *	2022-11-28	2023-12-12	广州佰芮慷生物科技有限公司	一种靶向人巨细胞病毒的嵌合抗原受体、car-nk细胞及用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1445243A (zh) *	2002-12-13	2003-10-01	中国疾病控制中心病毒病预防控制所	抗人巨细胞病毒人源中和性基因工程Fab抗体
AU2004215125B2 (en) *	2003-02-26	2011-01-06	Institute For Research In Biomedicine	Monoclonal antibody production by EBV transformation of B cells
WO2006124269A2 (en) *	2005-05-16	2006-11-23	Amgen Fremont Inc.	Human monoclonal antibodies that bind to very late antigen-1 for the treatment of inflammation and other disorders

2007
- 2007-12-17 ES ES07857724T patent/ES2363992T3/es active Active
- 2007-12-17 DK DK07857724.4T patent/DK2126049T3/da active
- 2007-12-17 WO PCT/EP2007/064094 patent/WO2008071806A1/en not_active Ceased
- 2007-12-17 DE DE602007013618T patent/DE602007013618D1/de active Active
- 2007-12-17 CN CN200780051422XA patent/CN101627115B/zh not_active Expired - Fee Related
- 2007-12-17 EA EA200970586A patent/EA018701B1/ru not_active IP Right Cessation
- 2007-12-17 AU AU2007331463A patent/AU2007331463B2/en not_active Ceased
- 2007-12-17 AT AT07857724T patent/ATE503769T1/de active
- 2007-12-17 US US12/519,236 patent/US8153129B2/en not_active Expired - Fee Related
- 2007-12-17 PT PT07857724T patent/PT2126049E/pt unknown
- 2007-12-17 BR BRPI0720464-7A2A patent/BRPI0720464A2/pt active Search and Examination
- 2007-12-17 PL PL07857724T patent/PL2126049T3/pl unknown
- 2007-12-17 JP JP2009540793A patent/JP5351041B2/ja not_active Expired - Fee Related
- 2007-12-17 EP EP07857724A patent/EP2126049B1/en active Active
- 2007-12-17 KR KR1020097014818A patent/KR20090114364A/ko not_active Withdrawn
- 2007-12-17 CA CA2672703A patent/CA2672703C/en not_active Expired - Fee Related
2009
- 2009-06-15 IL IL199366D patent/IL199366A/en not_active IP Right Cessation
- 2009-07-14 NO NO20092671A patent/NO20092671L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2672703C (en)	2016-11-22
US20100040602A1 (en)	2010-02-18
NO20092671L (no)	2009-09-03
AU2007331463B2 (en)	2014-03-27
ES2363992T3 (es)	2011-08-22
JP2010512736A (ja)	2010-04-30
BRPI0720464A2 (pt)	2014-01-14
EP2126049A1 (en)	2009-12-02
CN101627115B (zh)	2013-05-29
DE602007013618D1 (de)	2011-05-12
AU2007331463A1 (en)	2008-06-19
KR20090114364A (ko)	2009-11-03
JP5351041B2 (ja)	2013-11-27
EP2126049B1 (en)	2011-03-30
PT2126049E (pt)	2011-07-04
DK2126049T3 (da)	2011-07-18
IL199366A (en)	2015-03-31
EA200970586A1 (ru)	2009-12-30
EA018701B1 (ru)	2013-10-30
ATE503769T1 (de)	2011-04-15
US8153129B2 (en)	2012-04-10
WO2008071806A1 (en)	2008-06-19
CA2672703A1 (en)	2008-06-19
CN101627115A (zh)	2010-01-13

Publication	Publication Date	Title
PT2126049E (pt)	2011-07-04	Anticorpos contra citomegalovírus humano (hcmv)
WO2012021786A3 (en)	2012-07-19	Anti-hemagglutinin antibody compositions and methods of use thereof
EA201000424A1 (ru)	2010-10-29	Антитела к il-23
EA201290131A1 (ru)	2012-08-30	Производные пурина или деазапурина для применения при лечении вирусных инфекций и других заболеваний
MX2010004482A (es)	2010-07-06	Anticuerpos anti-proteina g vsr.
EP4349868A3 (en)	2024-08-28	Humanized and chimeric monoclonal antibodies to cd47
PH12012501308A1 (en)	2013-01-21	Binding members for human cytomegalovirus
UA100507C2 (ru)	2013-01-10	Предупреждение и лечение субклинической формы болезней, вызываемых цирковирусом свиней (pcvd)
UA94452C2 (ru)	2011-05-10	Гуманизированные моноклональные антитела к фактору роста гепатоцитов
UA109658C2 (xx)	2015-09-25	Антитіло проти cgrp
UA108193C2 (uk)	2015-04-10	Апоптозіндукуючий засіб для лікування раку і імунних і аутоімунних захворювань
MX2009006327A (es)	2009-06-23	Compuestos heterociclicos y metodos de uso de los mismos.
WO2009114560A3 (en)	2009-11-12	Compositions and methods for the therapy and diagnosis of cytomegalovirus infections
DE602007010764D1 (en)	2011-01-05	Benzamidglucokinaseaktivatoren
TN2009000380A1 (en)	2010-12-31	Novel human anti-r7v antibodies and uses thereof
MX2007011545A (es)	2008-03-11	Combinaciones para el tratamiento de cancer que comprenden el anticuerpo anti-egfr e inhibidores de vegfr.
CA2725873A1 (en)	2009-12-10	Monoclonal antibodies to basic fibroblast growth factor
GB2453491A (en)	2009-04-08	Immunogenic proteins of burkholderia pseudomallei and uses thereof
EP2555798A4 (en)	2013-11-20	METHOD AND COMPOSITIONS FOR INHIBITING HIV TRANSMISSIONS
WO2010135521A3 (en)	2011-05-05	Compositions and methods for the therapy and diagnosis of influenza
GEP201606595B (en)	2017-01-10	(r) -nifuratel, its use for the treatment of infections and synthesis of (r) and (s) –nifuratel
MX2009003301A (es)	2009-07-15	Novedoso inmunogeno neutralizante (nimiv) de rhinovirus y su uso para aplicaciones de vacunas.
MX2013004906A (es)	2013-12-06	Nuevos inhibidores especificos de la proteasa ns3 de hcv.
EA200970735A1 (ru)	2010-02-26	Антитела, специфичные для вируса varicella zoster
PH12013500432A1 (en)	2017-08-23	Anti-vegfr-3 antibody compositions